Literature DB >> 31140074

Is Stem Cell Commerce in Small Animal Therapies Scientifically and Morally Justified?

Luane Lopes Pinheiro1, Ana Rita de Lima2, Érika Branco2.   

Abstract

The lack of clear regulations for the use of veterinary stem cells has triggered the commercialization of unproven experimental therapies for companion animal diseases. Adult stem cells have complex biological characteristics that are directly related to the therapeutic application, but several questions remain to be answered. In order to regulate the use of these cells, well-conducted, controlled scientific studies that generate high-quality data should be performed, in order to assess the efficacy and safety of the intended treatment. This paper discusses the scientific challenges of mesenchymal stem cell therapy in veterinary regenerative medicine, and reviews published trials of adipose-tissue-derived stem cells in companion animal diseases that spontaneously occur.

Keywords:  Adipose-derived stem cell (ASC); Cat; Cell therapy; Dog; Small animal

Year:  2019        PMID: 31140074     DOI: 10.1007/s12015-019-09898-z

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  102 in total

Review 1.  Out of Eden: stem cells and their niches.

Authors:  F M Watt; B L Hogan
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

Review 2.  Mesenchymal stem cells as trophic mediators.

Authors:  Arnold I Caplan; James E Dennis
Journal:  J Cell Biochem       Date:  2006-08-01       Impact factor: 4.429

3.  Mesenchymal stem cells reside in virtually all post-natal organs and tissues.

Authors:  Lindolfo da Silva Meirelles; Pedro Cesar Chagastelles; Nance Beyer Nardi
Journal:  J Cell Sci       Date:  2006-05-09       Impact factor: 5.285

4.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

Review 5.  Adipose-derived stem cells for regenerative medicine.

Authors:  Jeffrey M Gimble; Adam J Katz; Bruce A Bunnell
Journal:  Circ Res       Date:  2007-05-11       Impact factor: 17.367

6.  Multilineage cells from human adipose tissue: implications for cell-based therapies.

Authors:  P A Zuk; M Zhu; H Mizuno; J Huang; J W Futrell; A J Katz; P Benhaim; H P Lorenz; M H Hedrick
Journal:  Tissue Eng       Date:  2001-04

7.  Comparison of osteogenic potentials of visceral and subcutaneous adipose-derived cells of rabbits.

Authors:  Ioana A Peptan; Liu Hong; Jeremy J Mao
Journal:  Plast Reconstr Surg       Date:  2006-04-15       Impact factor: 4.730

8.  Mesenchymal stem cells from rat visceral fat exhibit multipotential differentiation in vitro.

Authors:  S S Tholpady; A J Katz; R C Ogle
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2003-05

9.  Differentiation of stromal-vascular cells isolated from canine adipose tissues in primary culture.

Authors:  P Wu; K Sato; S Yukawa; Y Hikasa; K Kagota
Journal:  J Vet Med Sci       Date:  2001-01       Impact factor: 1.267

10.  Mesenchymal stem cells avoid allogeneic rejection.

Authors:  Jennifer M Ryan; Frank P Barry; J Mary Murphy; Bernard P Mahon
Journal:  J Inflamm (Lond)       Date:  2005-07-26       Impact factor: 4.981

View more
  1 in total

1.  Intra-Articular Injections of Allogeneic Mesenchymal Stromal Cells vs. High Molecular Weight Hyaluronic Acid in Dogs With Osteoarthritis: Exploratory Data From a Double-Blind, Randomized, Prospective Clinical Trial.

Authors:  Sohyun Kim; Lindsay Elam; Valerie Johnson; Ann Hess; Tracy Webb; Steven Dow; Felix Duerr
Journal:  Front Vet Sci       Date:  2022-06-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.